3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
43
Terminated
6
Recruiting
6
Withdrawn
3
Unknown
2
No longer available
1
Available
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
4
Sarcoma
1
Lymphoid
1
Genitourinary
1
Conditions
Sarcoma
112
Osteosarcoma
41
Sarcoma, Ewing
30
Rhabdomyosarcoma
28
Melanoma
28
Neuroblastoma
21
Bone Neoplasms
19
Glioblastoma
18
Rhabdoid Tumor
17
Lymphoma, Non-Hodgkin
17
Gliosarcoma
16
Neoplasms
15
Neoplasm Metastasis
15
Liposarcoma
15
Breast Neoplasms
15
Wilms Tumor
14
Ovarian Neoplasms
14
Glioma
14
Medulloblastoma
13
Leiomyosarcoma
13
Gastrointestinal Stromal Tumors
13
Carcinoma, Non-Small-Cell Lung
13
Hepatoblastoma
12
Colorectal Neoplasms
12
Carcinoma, Renal Cell
12
Stomach Neoplasms
11
Sarcoma, Synovial
11
Ependymoma
11
Chordoma
11
Neurofibrosarcoma
10
Interventions
CLR1404
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Neuroectodermal Tumors, Primitive
×
Sarcoma
×
Clear all
NCT03478462
2026-03-18
CLOVER-2
Cellectar Biosciences, Inc.
Phase 1
Active not recruiting
30 enrolled